Pharming Group to report first quarter 2026 financial results and provide business update on May 7
Pharming Group, a global biopharmaceutical company listed on Euronext Amsterdam and Nasdaq, will report its preliminary first quarter 2026 financial results along with a business update on May 7, 2026, followed by a conference call and webcast for investors and analysts.